Tag: FDA
Global Biosimilar Markets: Europe vs United States Comparison
By Joe Barnett On 15 Apr, 2026 Comments (10)
A detailed comparison of biosimilar markets in Europe and the US, exploring regulatory shifts, patent cliffs, and the race for healthcare cost reduction.
View MoreHistory of Generic Drugs in the United States: How Cheap Medicines Became the Norm
By Joe Barnett On 20 Jan, 2026 Comments (7)
Generic drugs now make up over 90% of U.S. prescriptions, saving billions annually. Their rise began with deadly drug failures, led by the Hatch-Waxman Act, and continues amid supply chain risks and quality concerns.
View More
